Quality of laparoscopic total mesorectal excision: Results from a single institution in China

Hepato-Gastroenterology

Volumn 62, Issue 138, 2015, Pages 264-267

  Deng, Haijun ^a   Chen, Hongyuan ^a   Zhao, Liying ^a   Shen, Zhiyong ^a   Wang, Yanan ^a   Lan, Xiaoliang ^a   Xue, Qi ^a   Liu, Hao ^a   Li, Guoxin ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Laparoscopic resection; Quality of mesorectum; Rectal cancer; Total mesorectal excision

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHINA; CLINICAL EVALUATION; EXCISION; FEMALE; HUMAN; INDEPENDENT VARIABLE; LAPAROSCOPIC SURGERY; LAPAROSCOPIC TOTAL MESORECTAL EXCISION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; RECTUM CANCER; RECTUM SURGERY; SURGICAL PATIENT; ADVERSE EFFECTS; BODY MASS; HEALTH CARE QUALITY; LAPAROSCOPY; MULTIVARIATE ANALYSIS; PATHOLOGY; PILOT STUDY; RECTAL NEOPLASMS; RISK; RISK FACTOR; STANDARDS; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CHEMORADIOTHERAPY, ADJUVANT; CHINA; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; LAPAROSCOPY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM STAGING; ODDS RATIO; PILOT PROJECTS; PROSPECTIVE STUDIES; QUALITY INDICATORS, HEALTH CARE; RECTAL NEOPLASMS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84928569954     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge14955     Document Type: Article

References (28)

1. Heald RJ, Ryall RD: Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1:1479-82.
2. Arbman G, Nilsson E, Hallbook O., Sjodahl R: Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 1996; 83:375-9.
3. Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH, et al: Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20:1729-34.
4. M.E.R.C.U.R.Y.: (Magnetic Resonance Imaging and Rectal cancer European Equivalence Study) ScD, I., Pelican Centre, north Hampshire Hospital, Basingstoke, Hampshire, UK, 2002.
5. Quirke P, Steele R, Monson J., Grieve R, Khanna S, Couture J., et al: Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG C016 randomised clinical trial. Lancet 2009; 373:821-8.
6. Garlipp B, Ptok H, Schmidt U., Stubs P, Scheidbach H, Meyer F., et al: Factors influencing the quality of total mesorectal excision. Br J Surg 2012; 99:714-20.
7. Jeyarajah S, Sutton CD, Miller A.S., Hemingway D., Leicester Colorectal Specialist G: Factors that influence the adequacy of total mesorectal excision for rectal cancer. Colorectal Dis 2007; 9:808-15.
8. Leonard D, Penninckx F, Fieuws S., Jouret-Mourin A, Sempoux C, Jehaes C., et al: Factors predicting the quality of total mesorectal excision for rectal cancer. Ann Surg 2010; 252:982-8.
9. Biondo S, Ortiz H, Lujan J., Codina-Cazador A, Espin E, Garcia-Granero E, et al: Quality of mesorectum after laparoscopic resection for rectal cancer - results of an audited teaching programme in Spain. Colorectal Dis 2010; 12:24-31.
10. Baik SH, Kim NK, Lee K.Y., Sohn SK, Cho CH, Kim MI, et al: Factors influencing pathologic results after total mesorectal excision for rectal cancer: analysis of consecutive 100 cases. Ann Surg Oncol 2008; 15:721-8.
11. Hermanek P, Hermanek P, Hohenberger W., Klimpfinger M, Kockerling F, Papadopoulos T: The pathological assessment of mesorectal excision: implications for further treatment and quality management. Int J Colorectal Dis 2003; 18:335-41.
12. Harnsberger JR, Vernava VM, 3rd, Longo WE: Radical abdominopelvic lymphadenectomy: historic perspective and current role in the surgical management of rectal cancer. Dis Colon Rectum 1994; 37:73-87.
13. Kapiteijn E, Marijnen CA, Colenbrander A.C., Klein Kranenbarg E, Steup WH, van Krieken JH, et al: Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands. Eur J Surg Oncol 1998; 24:528-35.
14. Hermanek P, Wiebelt H, Staimmer D., Riedl S: Prognostic factors of rectum carcinoma-experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori 1995; 81:60-4.
15. Heald RJ, Husband EM, Ryall RD: The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br J Surg 1982; 69:613-6.
16. Biondo S, Navarro M, Marti-Rague J, Arriola E., Pares D, Del Rio C, et al: Response to neoadjuvant therapy for rectal cancer: influence on long-term results. Colorectal Dis 2005; 7:472-9.
17. Bolognese A, Cardi M, Muttillo I.A., Barbarosos A., Bocchetti T, Valabrega S: Total mesorectal excision for surgical treatment of rectal cancer. J Surg Oncol 2000; 74:21-3.
18. Maslekar S, Sharma A, Macdonald A., Gunn J, Monson JR, Hartley JE: Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum 2007; 50:168-75.
19. Herzog T, Belyaev O, Chromik A.M., Weyhe D., Mueller CA, Munding J, et al: TME quality in rectal cancer surgery. Eur J Med Res 2010; 15:292-6.
20. Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P, Dutch Colorectal Cancer G, et al: Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005; 23:9257-64.
21. Pikarsky AJ, Saida Y, Yamaguchi T., Martinez S, Chen W, Weiss E.G., et al: Is obesity a high-risk factor for laparoscopic colorectal surgery? Surg Endosc 2002; 16:855-8.
22. Gendall KA, Raniga S, Kennedy R., Frizelle FA: The impact of obesity on outcome after major colorectal surgery. Dis Colon Rectum 2007; 50:2223-37.
23. Bege T, Lelong B, Francon D., Turrini O, Guiramand J, Delpero JR: Impact of obesity on short-term results of laparoscopic rectal cancer resection. Surg Endosc 2009; 23:1460-4.
24. Torkzad MR, Lindholm J, Martling A., Cedermark B, Glimelius B, Blomqvist L: MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry. Eur Radiol 2007; 17:1566-73.
25. Quirke P, Durdey P, Dixon M.F., Williams NS: Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2:996-9.
26. Adam IJ, Mohamdee MO, Martin I.G., Scott N., Finan PJ, Johnston D, et al: Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344:707-11.
27. Guillou PJ, Quirke P, Thorpe H., Walker J, Jayne DG, Smith A.M., et al: Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005; 365:1718-26.
28. Tepper JE, O'Connell MJ, Niedzwiecki D, Hollis D., Compton C, Benson AB, 3rd, et al: Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001; 19:157-63.